Literature DB >> 2568300

Pharmacological effect of somatostatin on bile secretion in man.

P Marteau1, Y Chrétien, Y Calmus, R Parc, R Poupon.   

Abstract

Somatostatin (SST) has been shown to induce cholestasis in the dog and in the rat. In man, it is still unknown whether SST modifies bile formation. The present study was undertaken to examine the influence of SST on bile secretion in man. Two volunteers who had a total external biliary fistula received 1-hour SST infusions (3.5 micrograms/kg/h). Bile flow, bile acid, phospholipid and cholesterol biliary outputs were measured before, during and 1 h after the infusion. The SST infusion was associated with a pronounced decrease in bile flow and in bile acid secretion and with an increase in bile cholesterol saturation. These findings suggest that SST has cholestatic properties in man as in other species. This may provide a rational explanation for the formation of gallstones and for the steatorrhea observed in patients with somatostatinomas or during therapeutic SST administration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568300     DOI: 10.1159/000199820

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  11 in total

1.  Gall stones induced by octreotide.

Authors:  S M Catnach; J A Wass; J V Anderson; M Besser; P Fairclough; H Hussaini; H Dowling
Journal:  BMJ       Date:  1992-08-01

Review 2.  Physiology of cholangiocytes.

Authors:  James H Tabibian; Anatoliy I Masyuk; Tetyana V Masyuk; Steven P O'Hara; Nicholas F LaRusso
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

3.  Increased deoxycholic acid absorption and gall stones in acromegalic patients treated with octreotide: more evidence for a connection between slow transit constipation and gall stones.

Authors:  A F Hofmann
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

4.  Effect of octreotide on dynamic excretion of bile in Chinese acromegalic patients assessed by [99mTc]EHIDA hepatobiliary scan.

Authors:  X F Zhu; A G Harris; M F Yang; Y F Shi; Q Zhou; J Y Xu; J X Zhang
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

5.  Cholescintigraphic study of effect of somatostatin analog, octreotide, on bile secretion and gallbladder emptying in normal subjects.

Authors:  C Grimaldi; J Darcourt; A G Harris; E Lebot; F Lapalus; J Delmont
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

6.  Gallstones in acromegalic patients undergoing different treatment regimens.

Authors:  K Schmidt; M Leuschner; A G Harris; P H Althoff; V Jacobi; E Jungmann; P M Schumm-Draeger; H Rau; C Braulke; K H Usadel
Journal:  Clin Investig       Date:  1992-07

Review 7.  Use of octreotide acetate for control of symptoms in patients with islet cell tumors.

Authors:  P N Maton
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

Review 8.  Drug-induced gallbladder disease. Incidence, aetiology and management.

Authors:  P P Michielsen; H Fierens; Y M Van Maercke
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

9.  Postprandial gallbladder motility and plasma cholecystokinin at regular time intervals after injection of octreotide in acromegalics on long-term treatment.

Authors:  W P Hopman; P A Van Liessum; G F Pieters; J B Jansen; C B Lamers; A G Smals; G Rosenbusch; P W Kloppenborg
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

10.  Conservative treatment of early postoperative small bowel obstruction with obliterative peritonitis.

Authors:  Jian-Feng Gong; Wei-Ming Zhu; Wen-Kui Yu; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.